Clinical Trials Browser

Phase 1/2 × Myeloid Malignancy × Azacitidine × Clear all

NCT07011186 2025-06-08

A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies

Phase 1/2 Recruiting

Myeloid Malignancy